aluates Reports

$ 0.0

Automative

Global Duloxetine Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-9F6102

Global and United States Duloxetine Market Report Forecast 2022 2028

BUY CHAPTERS

Global Duloxetine Market Research Report 2025

Code: QYRE-Auto-9F6102

Report

September 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

TEVA

Lupin Ltd

Sun Pharma

Zydus Pharmaceuticals

Torrent Pharmaceuticals

Aurobindo Pharma

Apotex

Breckenridge

Macleods

Ajanta Pharma

CSPC Ouyi Pharm

Jiangsu Nhwa Pharmaceutical

Duloxetine Market Size

The global market for Duloxetine was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 303 million by 2031, growing at a CAGR of 4.7% during the forecast period.

Duloxetine Market

Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.

Duloxetine is a medication used primarily to treat major depressive disorder, generalized anxiety disorder, and chronic pain conditions such as fibromyalgia and neuropathic pain. The market for duloxetine is driven by several factors. Depression and anxiety are common mental health disorders affecting a significant percentage of the population worldwide. The growing prevalence of these disorders is one of the key drivers of the duloxetine market. As awareness about mental health and the availability of treatment options increases, more and more patients are seeking medical help for their depression and anxiety. This heightened awareness has driven demand for medications like duloxetine. Chronic pain conditions like fibromyalgia and neuropathic pain are a growing healthcare concern. Duloxetine has been approved by the FDA for use in managing several chronic pain conditions, which has driven its market growth. The elderly population is more susceptible to depression, anxiety, and chronic pain conditions. With the aging of the baby boomer generation, there is a greater demand for medications like duloxetine. While duloxetine is effective in treating depression, anxiety, and chronic pain, there are other medications available in the market for managing these conditions. Competing medications can drive innovation and further demand for duloxetine.

This report aims to provide a comprehensive presentation of the global market for Duloxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duloxetine.

The Duloxetine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Duloxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Duloxetine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Duloxetine Market Report

Report Metric	Details
Report Name	Duloxetine Market
Accounted market size in year	US$ 221 million
Forecasted market size in 2031	US$ 303 million
CAGR	4.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	20mg Capsules 30mg Capsules 40mg Capsules 60mg Capsules
Segment by Application	Hospital Drug store
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eli Lilly, Teva, Lupin, Sun Pharma, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Aurobindo Pharma, Apotex, Breckenridge, MACLEODS, Ajanta Pharma, CSPC Ouyi Pharm, Jiangsu Nhwa Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Duloxetine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Duloxetine Market growing?

Ans: The Duloxetine Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the Duloxetine Market size in 2031?

Ans: The Duloxetine Market size in 2031 will be US$ 303 million.

Who are the main players in the Duloxetine Market report?

Ans: The main players in the Duloxetine Market are Eli Lilly, Teva, Lupin, Sun Pharma, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Aurobindo Pharma, Apotex, Breckenridge, MACLEODS, Ajanta Pharma, CSPC Ouyi Pharm, Jiangsu Nhwa Pharmaceutical

What are the Application segmentation covered in the Duloxetine Market report?

Ans: The Applications covered in the Duloxetine Market report are Hospital, Drug store

What are the Type segmentation covered in the Duloxetine Market report?

Ans: The Types covered in the Duloxetine Market report are 20mg Capsules, 30mg Capsules, 40mg Capsules, 60mg Capsules

Recommended Reports

Antidepressant Markets

Fibromyalgia & Pain

Mental Health Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Duloxetine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 20mg Capsules

1.2.3 30mg Capsules

1.2.4 40mg Capsules

1.2.5 60mg Capsules

1.3 Market by Application

1.3.1 Global Duloxetine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drug store

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Duloxetine Market Perspective (2020-2031)

2.2 Global Duloxetine Growth Trends by Region

2.2.1 Global Duloxetine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Duloxetine Historic Market Size by Region (2020-2025)

2.2.3 Duloxetine Forecasted Market Size by Region (2026-2031)

2.3 Duloxetine Market Dynamics

2.3.1 Duloxetine Industry Trends

2.3.2 Duloxetine Market Drivers

2.3.3 Duloxetine Market Challenges

2.3.4 Duloxetine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Duloxetine Players by Revenue

3.1.1 Global Top Duloxetine Players by Revenue (2020-2025)

3.1.2 Global Duloxetine Revenue Market Share by Players (2020-2025)

3.2 Global Duloxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Duloxetine Revenue

3.4 Global Duloxetine Market Concentration Ratio

3.4.1 Global Duloxetine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Duloxetine Revenue in 2024

3.5 Global Key Players of Duloxetine Head office and Area Served

3.6 Global Key Players of Duloxetine, Product and Application

3.7 Global Key Players of Duloxetine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Duloxetine Breakdown Data by Type

4.1 Global Duloxetine Historic Market Size by Type (2020-2025)

4.2 Global Duloxetine Forecasted Market Size by Type (2026-2031)

5 Duloxetine Breakdown Data by Application

5.1 Global Duloxetine Historic Market Size by Application (2020-2025)

5.2 Global Duloxetine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Duloxetine Market Size (2020-2031)

6.2 North America Duloxetine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Duloxetine Market Size by Country (2020-2025)

6.4 North America Duloxetine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Duloxetine Market Size (2020-2031)

7.2 Europe Duloxetine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Duloxetine Market Size by Country (2020-2025)

7.4 Europe Duloxetine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Duloxetine Market Size (2020-2031)

8.2 Asia-Pacific Duloxetine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Duloxetine Market Size by Region (2020-2025)

8.4 Asia-Pacific Duloxetine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Duloxetine Market Size (2020-2031)

9.2 Latin America Duloxetine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Duloxetine Market Size by Country (2020-2025)

9.4 Latin America Duloxetine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Duloxetine Market Size (2020-2031)

10.2 Middle East & Africa Duloxetine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Duloxetine Market Size by Country (2020-2025)

10.4 Middle East & Africa Duloxetine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Details

11.1.2 Eli Lilly Business Overview

11.1.3 Eli Lilly Duloxetine Introduction

11.1.4 Eli Lilly Revenue in Duloxetine Business (2020-2025)

11.1.5 Eli Lilly Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Duloxetine Introduction

11.2.4 Teva Revenue in Duloxetine Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Lupin

11.3.1 Lupin Company Details

11.3.2 Lupin Business Overview

11.3.3 Lupin Duloxetine Introduction

11.3.4 Lupin Revenue in Duloxetine Business (2020-2025)

11.3.5 Lupin Recent Development

11.4 Sun Pharma

11.4.1 Sun Pharma Company Details

11.4.2 Sun Pharma Business Overview

11.4.3 Sun Pharma Duloxetine Introduction

11.4.4 Sun Pharma Revenue in Duloxetine Business (2020-2025)

11.4.5 Sun Pharma Recent Development

11.5 Zydus Pharmaceuticals

11.5.1 Zydus Pharmaceuticals Company Details

11.5.2 Zydus Pharmaceuticals Business Overview

11.5.3 Zydus Pharmaceuticals Duloxetine Introduction

11.5.4 Zydus Pharmaceuticals Revenue in Duloxetine Business (2020-2025)

11.5.5 Zydus Pharmaceuticals Recent Development

11.6 Torrent Pharmaceuticals

11.6.1 Torrent Pharmaceuticals Company Details

11.6.2 Torrent Pharmaceuticals Business Overview

11.6.3 Torrent Pharmaceuticals Duloxetine Introduction

11.6.4 Torrent Pharmaceuticals Revenue in Duloxetine Business (2020-2025)

11.6.5 Torrent Pharmaceuticals Recent Development

11.7 Aurobindo Pharma

11.7.1 Aurobindo Pharma Company Details

11.7.2 Aurobindo Pharma Business Overview

11.7.3 Aurobindo Pharma Duloxetine Introduction

11.7.4 Aurobindo Pharma Revenue in Duloxetine Business (2020-2025)

11.7.5 Aurobindo Pharma Recent Development

11.8 Apotex

11.8.1 Apotex Company Details

11.8.2 Apotex Business Overview

11.8.3 Apotex Duloxetine Introduction

11.8.4 Apotex Revenue in Duloxetine Business (2020-2025)

11.8.5 Apotex Recent Development

11.9 Breckenridge

11.9.1 Breckenridge Company Details

11.9.2 Breckenridge Business Overview

11.9.3 Breckenridge Duloxetine Introduction

11.9.4 Breckenridge Revenue in Duloxetine Business (2020-2025)

11.9.5 Breckenridge Recent Development

11.10 MACLEODS

11.10.1 MACLEODS Company Details

11.10.2 MACLEODS Business Overview

11.10.3 MACLEODS Duloxetine Introduction

11.10.4 MACLEODS Revenue in Duloxetine Business (2020-2025)

11.10.5 MACLEODS Recent Development

11.11 Ajanta Pharma

11.11.1 Ajanta Pharma Company Details

11.11.2 Ajanta Pharma Business Overview

11.11.3 Ajanta Pharma Duloxetine Introduction

11.11.4 Ajanta Pharma Revenue in Duloxetine Business (2020-2025)

11.11.5 Ajanta Pharma Recent Development

11.12 CSPC Ouyi Pharm

11.12.1 CSPC Ouyi Pharm Company Details

11.12.2 CSPC Ouyi Pharm Business Overview

11.12.3 CSPC Ouyi Pharm Duloxetine Introduction

11.12.4 CSPC Ouyi Pharm Revenue in Duloxetine Business (2020-2025)

11.12.5 CSPC Ouyi Pharm Recent Development

11.13 Jiangsu Nhwa Pharmaceutical

11.13.1 Jiangsu Nhwa Pharmaceutical Company Details

11.13.2 Jiangsu Nhwa Pharmaceutical Business Overview

11.13.3 Jiangsu Nhwa Pharmaceutical Duloxetine Introduction

11.13.4 Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2020-2025)

11.13.5 Jiangsu Nhwa Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

TEVA

Lupin Ltd

Sun Pharma

Zydus Pharmaceuticals

Torrent Pharmaceuticals

Aurobindo Pharma

Apotex

Breckenridge

Macleods

Ajanta Pharma

CSPC Ouyi Pharm

Jiangsu Nhwa Pharmaceutical

List of Tables

Table 1. Global Duloxetine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 20mg Capsules

Table 3. Key Players of 30mg Capsules

Table 4. Key Players of 40mg Capsules

Table 5. Key Players of 60mg Capsules

Table 6. Global Duloxetine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Duloxetine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Duloxetine Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Duloxetine Market Share by Region (2020-2025)

Table 10. Global Duloxetine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Duloxetine Market Share by Region (2026-2031)

Table 12. Duloxetine Market Trends

Table 13. Duloxetine Market Drivers

Table 14. Duloxetine Market Challenges

Table 15. Duloxetine Market Restraints

Table 16. Global Duloxetine Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Duloxetine Market Share by Players (2020-2025)

Table 18. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duloxetine as of 2024)

Table 19. Ranking of Global Top Duloxetine Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Duloxetine Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Duloxetine, Headquarters and Area Served

Table 22. Global Key Players of Duloxetine, Product and Application

Table 23. Global Key Players of Duloxetine, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Duloxetine Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Duloxetine Revenue Market Share by Type (2020-2025)

Table 27. Global Duloxetine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Duloxetine Revenue Market Share by Type (2026-2031)

Table 29. Global Duloxetine Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Duloxetine Revenue Market Share by Application (2020-2025)

Table 31. Global Duloxetine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Duloxetine Revenue Market Share by Application (2026-2031)

Table 33. North America Duloxetine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Duloxetine Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Duloxetine Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Duloxetine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Duloxetine Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Duloxetine Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Duloxetine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Duloxetine Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Duloxetine Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Duloxetine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Duloxetine Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Duloxetine Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Duloxetine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Duloxetine Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Duloxetine Market Size by Country (2026-2031) & (US$ Million)

Table 48. Eli Lilly Company Details

Table 49. Eli Lilly Business Overview

Table 50. Eli Lilly Duloxetine Product

Table 51. Eli Lilly Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 52. Eli Lilly Recent Development

Table 53. Teva Company Details

Table 54. Teva Business Overview

Table 55. Teva Duloxetine Product

Table 56. Teva Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 57. Teva Recent Development

Table 58. Lupin Company Details

Table 59. Lupin Business Overview

Table 60. Lupin Duloxetine Product

Table 61. Lupin Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 62. Lupin Recent Development

Table 63. Sun Pharma Company Details

Table 64. Sun Pharma Business Overview

Table 65. Sun Pharma Duloxetine Product

Table 66. Sun Pharma Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 67. Sun Pharma Recent Development

Table 68. Zydus Pharmaceuticals Company Details

Table 69. Zydus Pharmaceuticals Business Overview

Table 70. Zydus Pharmaceuticals Duloxetine Product

Table 71. Zydus Pharmaceuticals Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 72. Zydus Pharmaceuticals Recent Development

Table 73. Torrent Pharmaceuticals Company Details

Table 74. Torrent Pharmaceuticals Business Overview

Table 75. Torrent Pharmaceuticals Duloxetine Product

Table 76. Torrent Pharmaceuticals Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 77. Torrent Pharmaceuticals Recent Development

Table 78. Aurobindo Pharma Company Details

Table 79. Aurobindo Pharma Business Overview

Table 80. Aurobindo Pharma Duloxetine Product

Table 81. Aurobindo Pharma Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 82. Aurobindo Pharma Recent Development

Table 83. Apotex Company Details

Table 84. Apotex Business Overview

Table 85. Apotex Duloxetine Product

Table 86. Apotex Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 87. Apotex Recent Development

Table 88. Breckenridge Company Details

Table 89. Breckenridge Business Overview

Table 90. Breckenridge Duloxetine Product

Table 91. Breckenridge Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 92. Breckenridge Recent Development

Table 93. MACLEODS Company Details

Table 94. MACLEODS Business Overview

Table 95. MACLEODS Duloxetine Product

Table 96. MACLEODS Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 97. MACLEODS Recent Development

Table 98. Ajanta Pharma Company Details

Table 99. Ajanta Pharma Business Overview

Table 100. Ajanta Pharma Duloxetine Product

Table 101. Ajanta Pharma Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 102. Ajanta Pharma Recent Development

Table 103. CSPC Ouyi Pharm Company Details

Table 104. CSPC Ouyi Pharm Business Overview

Table 105. CSPC Ouyi Pharm Duloxetine Product

Table 106. CSPC Ouyi Pharm Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 107. CSPC Ouyi Pharm Recent Development

Table 108. Jiangsu Nhwa Pharmaceutical Company Details

Table 109. Jiangsu Nhwa Pharmaceutical Business Overview

Table 110. Jiangsu Nhwa Pharmaceutical Duloxetine Product

Table 111. Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2020-2025) & (US$ Million)

Table 112. Jiangsu Nhwa Pharmaceutical Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Duloxetine Picture

Figure 2. Global Duloxetine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Duloxetine Market Share by Type: 2024 VS 2031

Figure 4. 20mg Capsules Features

Figure 5. 30mg Capsules Features

Figure 6. 40mg Capsules Features

Figure 7. 60mg Capsules Features

Figure 8. Global Duloxetine Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Duloxetine Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Drug store Case Studies

Figure 12. Duloxetine Report Years Considered

Figure 13. Global Duloxetine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Duloxetine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Duloxetine Market Share by Region: 2024 VS 2031

Figure 16. Global Duloxetine Market Share by Players in 2024

Figure 17. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duloxetine as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Duloxetine Revenue in 2024

Figure 19. North America Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Duloxetine Market Share by Country (2020-2031)

Figure 21. United States Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Duloxetine Market Share by Country (2020-2031)

Figure 25. Germany Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Duloxetine Market Share by Region (2020-2031)

Figure 33. China Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Duloxetine Market Share by Country (2020-2031)

Figure 41. Mexico Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Duloxetine Market Share by Country (2020-2031)

Figure 45. Turkey Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Duloxetine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Eli Lilly Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 49. Teva Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 50. Lupin Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 51. Sun Pharma Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 52. Zydus Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 53. Torrent Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 54. Aurobindo Pharma Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 55. Apotex Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 56. Breckenridge Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 57. MACLEODS Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 58. Ajanta Pharma Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 59. CSPC Ouyi Pharm Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 60. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in Duloxetine Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Anti depressant Drugs Market

Global Antidepressants Drugs Market Insights Forecast to 2030

Duloxetine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Duloxetine Hydrochloride API Market Research Report 2025

Global Sertraline Market Insights Forecast to 2030

Duloxetine Hydrochloride Enteric Coated Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nortriptyline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paroxetine Market Insights Forecast to 2030

Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030

Global Mirtazapine Tablets Market Research Report 2024

Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Depression Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paroxetine Hydrochloride Tablet Market Research Report 2024

Global Venlafaxine Hydrochloride Extended Release Capsules Market Research Report 2024

Global ADHD Medications Market Insights Forecast to 2030

Global Cardiometabolic Drug Market Insights Forecast to 2030

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global Obsessive Compulsive Disorder Drugs Market Insights Forecast to 2030

Global Mental Health Medications Market Research Report 2025

Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions